People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the ...

Eli Lilly is lowering the cost barrier to its weight loss drug Zepbound. For many consumers, their insurance denies them coverage for weight loss drugs. Now, for those who have to pay out-of ...

Rebelo joined Grey Health New York in December 2023 as executive creative director after spending nearly three-and-a-half years as chief creative officer at McCann Health New Jersey.

Tony Ezell serves as the executive vice president, president of the Americas for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New ...

A new study funded by Eli Lilly reports that people without diabetes ... chief of endocrinology at Hackensack Meridian Jersey Shore University Medical Center in New Jersey, about this research.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...